Entity
  • Sonoma Biotherapeutics

    Created in 2020
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,648 318 14,315
  • Activities

  • Technologies

  • Entity types

  • Location

    201 Haskins Way, South San Francisco, CA 94080, USA

    South San Francisco

    United States of America

  • Employees

    Scale: 51-200

    Estimated: 131

  • Engaged corporates

    1
    1 1
  • Added in Motherbase

    2 years, 5 months ago
Description
  • Value proposition

    Leading the Next Frontier of Cell Therapy

    Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.

    cell therapy and autoimmune disease

  • Sonoma Biotherapeutics

    Developing living cell therapies designed to restore balance to the immune system and ultimately cure autoimmune and inflammatory disease.

  • https://sonomabio.com/
Corporate interactions BETA
Corporate TypeTweets Articles
Regeneron
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research
Regeneron
Pharmaceutical, Biotechnology, Biotechnology Research
Other

6 Sep 2024


Similar entities
Loading...
Loading...
Social network dynamics